PAO Group

Curated by Signal

Developer of cannabis-based therapeutics for respiratory diseases

Overview

Developer of cannabis-based therapeutics for respiratory diseases. The product RespRx is a CBD formulation that improves lung function and inspiratory airflow. It is used for the treatment of symptoms associated with chronic obstructive pulmonary disease and covid-19.

Key facts

Founded: 2020
Headquarters: Sandusky, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Movedocs
Online document management solution for healthcare providers and lawyers
Health TechnologyLas Vegas, United States
Capitan
Cloud-based management software for climbing gyms
Health TechnologyDenver, United States
HealthCubed
Patient management & diagnostic tool
Health TechnologyBethesda, United States

About PAO Group

What does PAO Group do?

Developer of cannabis-based therapeutics for respiratory diseases.

Where is PAO Group headquartered?

PAO Group is headquartered in Sandusky, United States.

When was PAO Group founded?

PAO Group was founded in 2020.

Which sector is PAO Group in?

PAO Group operates in Health Technology.

Who are PAO Group's competitors?

Companies similar to PAO Group include Movedocs, Capitan, and HealthCubed.